Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05820555 · ClinicalTrials.gov registry record · NA

The Goodnight Screen Media Study

A NA study of Sleep and Sleep Hygiene, sponsored by Baylor College of Medicine.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT05820555 is a NA study of Sleep and Sleep Hygiene that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 180 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05820555, a NA study of Sleep and Sleep Hygiene, is actively recruiting participants, sponsored by Baylor College of Medicine.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

To test the timing of evening tablet use on children's circadian phase and sleep (i.e., sleep onset and sleep duration) compared to no screen media use. To explore the effect of evening tablet use on children's inhibitory control and executive function.

Conditions Studied

Interventions

  • BEHAVIORAL Timed evening technology and digital media use (tablet use)
  • BEHAVIORAL no technology and digital media use (screen media use)

Study Locations (1)

Texas

  • Children's Nutrition Research Center - Houston

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2023-04-24
Est. Completion 2026-08-31
Phase NA

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT05820555

The ClinicalTrials.gov registry entry for NCT05820555 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (96% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Timed evening technology and digital media use (tablet use) is the first listed.

NCT05820555 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05820555 about?

NCT05820555 is a clinical study titled "The Goodnight Screen Media Study". To test the timing of evening tablet use on children's circadian phase and sleep (i.e., sleep onset and sleep duration) compared to no screen media use. To explore the effect of evening tablet use on children's inhibitory control and executive function.

What is the current status of trial NCT05820555?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-04-24. Estimated completion is 2026-08-31.

What conditions does trial NCT05820555 study?

This clinical trial studies the following conditions: Sleep, Sleep Hygiene.

What interventions are being tested in trial NCT05820555?

The interventions under investigation include: Timed evening technology and digital media use (tablet use) (BEHAVIORAL), no technology and digital media use (screen media use) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05820555?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05820555 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.